United States, Oct. 15 -- GE HealthCare announced that its MINItrace Magni cyclotron has achieved CE Mark and that its PETtrace Solid Target Platform is expanding beyond Gallium-68 with support for Copper-64 (??Cu) production. Together, the developments reflect the company's focus on helping institutions build the production capabilities behind their molecular imaging programs-from establishing local PET radioisotope production to supporting research into emerging radiopharmaceuticals.For healthcare providers building or expanding a positron emission tomography (PET) program, access to tracers is an important consideration. Many PET radioisotopes have short half-lives, making proximity between production and use a factor in supply planning....